| DIRECT COMPETITOR COMPARISON | |
| PBH | CLX | JNJ | PG | Industry | | Market Cap: | 398.23M | 8.65B | 178.51B | 179.04B | 114.27M | | Employees: | 98 | 8,300 | 118,700 | 135,000 | 280 | | Qtrly Rev Growth (yoy): | -1.60% | -0.90% | -5.30% | -5.60% | 9.60% | | Revenue (ttm): | 311.37M | 5.44B | 60.53B | 77.85B | 71.35M | | Gross Margin (ttm): | 52.09% | 44.47% | 71.08% | 51.53% | 52.09% | | EBITDA (ttm): | 95.61M | 1.29B | 19.05B | 19.23B | 724.20K | | Oper Margins (ttm): | 26.92% | 20.12% | 26.94% | 20.79% | 10.17% | | Net Income (ttm): | -184.65M | 567.00M | 12.77B | 11.01B | N/A | | EPS (ttm): | -3.698 | 4.012 | 4.579 | 4.291 | N/A | | P/E (ttm): | N/A | 15.43 | 14.13 | 14.28 | 18.13 | | PEG (5 yr expected): | 1.03 | 1.55 | 1.87 | 1.58 | 0.97 | | P/S (ttm): | 1.29 | 1.59 | 2.94 | 2.30 | 1.28 |
|
| CLX = Clorox Corporation | | JNJ = Johnson & Johnson | | PG = Procter & Gamble Co. | | Industry = Drug Related Products | |
| BIOTECHNOLOGY COMPANIES RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Amgen Inc. | AMGN | 57.42 | 0.12% | 58.12B | 12.52 | | Genentech, Inc. | Private - View Profile | | Biogen Idec Inc. | BIIB | 52.24 | 0.15% | 15.11B | 17.48 | | Genzyme Corp. | GENZ | 48.50 | 0.62% | 12.87B | 27.65 | | Merck Serono S.A. | Private - View Profile | | Chiron Corporation | Private - View Profile | | Gilead Sciences Inc. | GILD | 43.00 | -0.02% | 38.70B | 16.63 | | MedImmune, Inc. | Private - View Profile | | Life Technologies Corporation | LIFE | 52.17 | 0.68% | 9.30B | 1064.69 | | Teva Pharmaceutical Industries Limited | TEVA | 55.94 | -0.07% | 49.28B | 51.18 |
|
| GENERIC DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Sandoz International GmbH | Private - View Profile | | Watson Pharmaceuticals Inc. | WPI | 39.91 | 0.28% | 4.24B | 20.57 | | King Pharmaceuticals Inc. | KG | 12.14 | -0.82% | 3.01B | N/A | | Ranbaxy Laboratories Limited | Private - View Profile | | Mylan, Inc. | MYL | 18.74 | 0.00% | 5.73B | 114.97 | | Pfizer Inc. | PFE | 18.60 | 0.11% | 150.09B | 15.45 | | Johnson & Johnson | JNJ | 64.70 | 0.20% | 178.51B | 14.13 | | GlaxoSmithKline plc | GSK | 42.29 | 0.48% | 107.21B | 13.87 | | Sanofi-Aventis | SNY | 39.87 | 0.43% | 104.11B | N/A | | Novartis AG | NVS | 54.84 | 0.44% | 124.55B | 16.42 |
|
| DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | RHHBY.PK | 43.20 | 0.93% | N/A | N/A | | AstraZeneca plc | AZN | 46.38 | 0.89% | 67.25B | 9.31 | | Abbott Laboratories | ABT | 54.15 | 0.11% | 83.76B | 14.67 | | Bristol-Myers Squibb Co. | BMY | 25.76 | 0.23% | 51.03B | 13.33 |
|
| NEWS ON DIRECT COMPETITORS | |
| • | PG | | Tiger Woods' Sponsors Jumping Ship
Sat 11:01pm -
at TheStreet.com | | • | JNJ | | [$$] Stocks Could Fall
Sat 8:44am -
at Barrons.com | | • | JNJ | | Wall Street's 10 Favorite Stocks Right Now
Sat 8:00am -
at Motley Fool | | • | JNJ | | Matthew Herper And Robert Langreth On The Pharmaceutical Industry
Thu, Dec 24 -
at Forbes.com | | • | PG | | Send A Strong Message
Thu, Dec 24 -
Investor's Business Daily | | • | JNJ | | Health-Care Reform: Two-Thirds Finished
Thu, Dec 24 -
at Motley Fool | | • | JNJ | | 5-Star Stocks Poised to Pop: National HealthCare
Thu, Dec 24 -
at Motley Fool | | • | PG | | A Terrible Decade for Stocks -- and Reason for Optimism
Thu, Dec 24 -
at Motley Fool | | • | PG | | [$$] For Ad Industry, 2010 Promises Scant Relief
Wed, Dec 23 -
at The Wall Street Journal Online | | • | PG | | Novartis Partnership And International Sales Position Cubist Pharmaceuticals As A Good Investment, According To Former Vice President Of Morgan Stanley
Wed, Dec 23 -
Wall Street Transcript | | • | CLX | | [$$] Don't Forget the Market's Emotional Side
Tue, Dec 22 -
at RealMoney by TheStreet.com | | • | CLX | | Sanofi-Chattem: Another Bet on the Global Consumer
Mon, Dec 21 -
at The Wall Street Journal Online | | • | CLX | | 4-Star Stocks Poised to Pop: Church & Dwight
Fri, Dec 18 -
at Motley Fool | | • | CLX | | Top Six Consumer Goods Stocks for 2010
Thu, Dec 17 -
at TheStreet.com | | • | CLX | | Top Six Consumer Goods Stocks for 2010
Thu, Dec 17 -
TheStreet.com | | • | CLX | | Which Consumer Goods Firm Will Win in 2010?
Thu, Dec 17 -
at TheStreet.com | | | All Headlines for these symbols... |
|
|
|
0.51% Nasdaq 
0.04 (0.50%) 
Competitors
